Zenosense, Inc.: Update on MIDS Medical Test Strip Development
March 20, 2019 07:30 ET
|
Zenosense, Inc.
VALENCIA, SPAIN, March 20, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Zenosense, Inc. (OTCQB: ZENO, "Zenosense", the "Company"), a healthcare technology company focused on the development and...
Zenosense, Inc.: MIDS Medical Expands Technical Team
October 02, 2018 07:30 ET
|
Zenosense, Inc.
VALENCIA, SPAIN, Oct. 02, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Zenosense, Inc. (OTCQB: ZENO, "Zenosense", the "Company"), a healthcare technology company focused on the development and...
Zenosense, Inc.: MIDS Medical JV to Receive Funding of Up to $1.2 Million
September 05, 2018 07:30 ET
|
Zenosense, Inc.
VALENCIA, SPAIN, Sept. 05, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Zenosense, Inc. (OTCQB: ZENO, "Zenosense", the "Company"), a healthcare technology company focused on the development and...
Zenosense Trading on the OTCQB Venture Market
July 10, 2018 08:00 ET
|
Zenosense, Inc.
VALENCIA, SPAIN, July 10, 2018 (GLOBE NEWSWIRE) -- Zenosense, Inc. (OTCQB: ZENO, "Zenosense", the "Company"), a healthcare technology company focused on the development and commercialization of the...
Zenosense, Inc.: Breakthrough Quantitative MIDS Testing Results
June 19, 2018 07:30 ET
|
Zenosense, Inc.
VALENCIA, SPAIN., June 19, 2018 (GLOBE NEWSWIRE) -- Zenosense, Inc. (OTC PINK: ZENO) ("Zenosense", the "Company"), a healthcare technology company focused on the development and commercialization of...
Zenosense, Inc.: MIDS Shareholder Update
May 24, 2018 08:43 ET
|
Zenosense, Inc.
VALENCIA, SPAIN, May 24, 2018 (GLOBE NEWSWIRE) -- Zenosense, Inc. (OTC PINK: ZENO) ("Zenosense", the "Company"), a healthcare technology company primarily focused on the development and...